Browsing Category

24283 posts

ESMO 2025: CStone Discloses Phase I Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody)

SUZHOU, China, Oct. 20, 2025 /PRNewswire/ — CStone Pharmaceuticals ("CStone," HKEX: 2616),…
Leading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group

Leading Competition Economist Dr. Luke Wainscoat Joins The Brattle Group

SYDNEY, Oct. 20, 2025 /PRNewswire/ — The Brattle Group has welcomed Dr. Luke…

Clover Appoints Nicholas Jackson, Ph.D., as President of Global R&D and Alliances

SHANGHAI, Oct. 20, 2025 /PRNewswire/ — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global…

Webull Reduces Minimum ASX Trading Fee To $1

Webull Australia now offers the lowest-cost CHESS-sponsored brokerage fee minimums for trading…
Yaber Expands Its Global Footprint — Now Available at JB Hi-Fi Across Australia

Yaber Expands Its Global Footprint — Now Available at JB Hi-Fi Across Australia

SYDNEY, Oct. 20, 2025 /PRNewswire/ — Yaber, a pioneer of entertainment projectors,…

Razor Labs Expands Predictive Maintenance Coverage in Australia with Mobile Fleet AI Solution Launch at IMARC 2025

The company introduces its proven Mobile Fleet Predictive Maintenance solution to Australia,…

Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025

HONG KONG, Oct. 19, 2025 /PRNewswire/ — On October 19, 2025, Akeso (9926.HK)…

HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet

Ivonescimab plus chemotherapy demonstrated a median PFS of 11.14 months, PFS HR=0.60,…